Thymine Kinase 2 Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Thymine Kinase 2 Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

AVAILABLENot Applicable

NCT06590493

Doxecitine and Doxribtimine-Expanded Access

This Expanded Access Record for doxecitine and doxribtimine includes the following managed access programs and status: TK0113: Available TK0115: Available

Location not specified

Treatment: doxecitine and doxribtimine